248 related articles for article (PubMed ID: 29246902)
1. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
2. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
3. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
Rothmeier AS; Versteeg HH; Ruf W
J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
[TBL] [Abstract][Full Text] [Related]
4. Activation of β1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival.
Åberg M; Edén D; Siegbahn A
Apoptosis; 2020 Aug; 25(7-8):519-534. PubMed ID: 32458278
[TBL] [Abstract][Full Text] [Related]
5. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.
Disse J; Petersen HH; Larsen KS; Persson E; Esmon N; Esmon CT; Teyton L; Petersen LC; Ruf W
J Biol Chem; 2011 Feb; 286(7):5756-67. PubMed ID: 21149441
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling.
Zelaya H; Grunz K; Nguyen TS; Habibi A; Witzler C; Reyda S; Gonzalez-Menendez I; Quintanilla-Martinez L; Bosmann M; Weiler H; Ruf W
Blood; 2024 Mar; 143(10):845-857. PubMed ID: 38096370
[TBL] [Abstract][Full Text] [Related]
7. TF:FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2.
Versteeg HH; Borensztajn KS; Kerver ME; Ruf W; Reitsma PH; Spek CA; Peppelenbosch MP
J Thromb Haemost; 2008 Sep; 6(9):1550-7. PubMed ID: 18647225
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC
J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200
[TBL] [Abstract][Full Text] [Related]
9. Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion.
Paul S; Das K; Ghosh A; Chatterjee A; Bhoumick A; Basu A; Sen P
J Thromb Haemost; 2023 Dec; 21(12):3522-3538. PubMed ID: 37579880
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
11. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
[TBL] [Abstract][Full Text] [Related]
12. Cortactin activation by FVIIa/tissue factor and PAR2 promotes endothelial cell migration.
Zhu T; Mancini JA; Sapieha P; Yang C; Joyal JS; Honoré JC; Leduc M; Zaniolo K; Hardy P; Shao Z; Fan L; Hou X; Rivard GE; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R577-85. PubMed ID: 21160057
[TBL] [Abstract][Full Text] [Related]
13. Emerging insights in tissue factor-dependent signaling events.
Versteeg HH; Ruf W
Semin Thromb Hemost; 2006 Feb; 32(1):24-32. PubMed ID: 16479459
[TBL] [Abstract][Full Text] [Related]
14. Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.
Guo D; Zhou H; Wu Y; Zhou F; Xu G; Wen H; Zhang X
Tumour Biol; 2011 Oct; 32(5):921-30. PubMed ID: 21625939
[TBL] [Abstract][Full Text] [Related]
15. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis.
Uusitalo-Jarvinen H; Kurokawa T; Mueller BM; Andrade-Gordon P; Friedlander M; Ruf W
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1456-62. PubMed ID: 17363687
[TBL] [Abstract][Full Text] [Related]
16. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
Aberg M; Johnell M; Wickström M; Siegbahn A
Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
[TBL] [Abstract][Full Text] [Related]
17. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.
Eriksson O; Ramström M; Hörnaeus K; Bergquist J; Mokhtari D; Siegbahn A
J Biol Chem; 2014 Nov; 289(47):32379-91. PubMed ID: 25281742
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
[TBL] [Abstract][Full Text] [Related]
19. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tissue factor signaling suppresses tumor growth.
Versteeg HH; Schaffner F; Kerver M; Petersen HH; Ahamed J; Felding-Habermann B; Takada Y; Mueller BM; Ruf W
Blood; 2008 Jan; 111(1):190-9. PubMed ID: 17901245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
